Drug use and acute leukemia

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue 2, 1998, Pages 113-123

  Traversa, Giuseppe ^a   Menniti Ippolito, Francesca ^a   Da Cas, Roberto ^a   Mele, Alfonso ^a   Pulsoni, Alessandro ^b   Mandelli, Franco ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute leukemia; Case control studies; Drugs and cancer

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANABOLIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIGOUT AGENT; ANTIPARKINSON AGENT; ANTIPYRETIC ANALGESIC AGENT; BUTYROPHENONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHLORAMPHENICOL DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; ESTROGEN DERIVATIVE; GESTAGEN; HORMONE DERIVATIVE; IMIDAZOLE DERIVATIVE; INSULIN DERIVATIVE; MACROLIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PENICILLIN DERIVATIVE; PHENOTHIAZINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031799238     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9     Document Type: Article

References (43)

1. Linet, M. S. The Leukemias: Epidemiologic Aspects. Oxford University Press, New York, 1985.
2. Askoy, M., Erdem, S. and Dincol, G. Leukemia in shoe-workers exposed chronically to benzene. Blood 1974; 44: 837-841.
3. Court-Brown, W. M. and Doll, R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. British Medical Journal 1965; 2: 1327-1332.
4. Matanoski, G. M., Seltser, R., Sartwell, P. E., Diamond, E. L. and Elliott, E. A. The current mortality rates of radiologists and other physician specialists: specific causes of death. American Journal of Epidemiology 1975; 101: 199-210.
5. Radford, E. P., Doll, R. and Smith, P. G. Mortality among patients with ankylosing spondylitis not given x-ray therapy. New England Journal of Medicine 1977; 297: 572-576.
6. Smith, P. G. and Doll, R. Late effects of X-irradiation in patients treated for metropathia haemorrhagica. British Journal of Radiology 1976; 49: 224-232.
7. Vigliani, E. C. and Forni, A. Benzene and leukemia. Environmental Research 1976; 11: 122-127.
8. Siegel, M. Smoking and leukemia: evaluation of a causal hypothesis. American Journal of Epidemiology 1993; 138: 1-9.
9. Thériault, G., Goldberg, M., Miller, A. B., et al. Cancer risk associated with occupational exposure to magnetic fields among electric workers in Ontario and Quebec, Canada, and France: 1970-1989. American Journal of Epidemiology 1994; 139: 550-572.
10. Mele, A., Szklo, M., Visani, G., et al. Hair dye use and other risk factors for leukemia and preleukemia: a case-control study. American Journal of Epidemiology 1994; 139: 609-619.
11. Shu, X. O., Linet, M. S., Gao, R. N., et al. Chloramphenicol use and childhood leukemia in Shanghai. Lancet 1987; ii: 934-937.
12. Fraumeni, J. F. Bone marrow depression induced by chloramphenicol or phenylbutazone. Leukemia and other sequelae. Journal of the American Medical Association 1967; 201: 828-834.
13. Cohen, T. and Creger, W. P. Acute myeloid leukemia following seven years of aplastic anemia induced by chloramphenicol. American Journal of Medicine 1967; 43: 762-770.
14. Cohen, H. J. and Huang, A. A marked chromosome abnormality. Occurrence in chloramphenicol-associated acute leukemia. Archives of Internal Medicine 1973; 132: 440-443.
15. Friedman, G. D. Phenylbutazone, musculoskeletal disease, and leukemia. Journal of Chronic Diseases 1982; 35: 233-243.
16. Askoy, M., Erdem, S., Tezel, H. and Tezel, T. Acute myeloblastic leukemia after propylthiouracil. Lancet 1974; i: 928-929.
17. Brood, R. C. Blood dyscrasias associated with tolbutamide therapy. Journal of the American Medical Association 1959; 171: 296-297.
18. Fradkin, J. E., Mills, J. L., Schonberger, L. B., et al. Risk of leukemia after treatment with pituitary growth hormone. Journal of the American Medical Association 1993; 270: 2829-2832.
19. Friedman, G. D. and Ury, H. K. Initial screening for carcinogenicity of commonly used drugs. Journal of the National Cancer Institute 1980; 65: 723-733.
20. Friedman, G. D. and Ury, H. K. Screening for possible drug carcinogenicity: second report of findings. Journal of the National Cancer Institute 1983; 71: 1165-1175.
21. Catovsky, D., Matutes, E., Buccheri, V., et al. A classification of acute leukemia for the 1990s. Annals of Hematology 1991; 62: 16-21.
22. Nordic Council on Medicines. Guideline for ATC Classification. NLN Publication, Uppsala (Sweden), 1990.
23. Kritchevsky, S. B. Cholesterol inhibition, cancer, and coronary heart disease. Lancet 1992; 340: 128.
24. Muldoon, M. F., Manuck, S. B. and Matthews, K. A. Lowering cholesterol concentration and mortality: a quantitative review of primary prevention trials. British Medical Journal 1990; 301: 309-314.
25. Pahor, M., Guralnik, J. M., Ferrucci, L., et al., Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-497.
26. Zheng, W., Linet, M. S., Shu, X. O., Pan, R. P., Gao, Y. T. and Fraumeni, J. F. Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes and Control 1993; 4: 361-368.
27. Wallerstein, R. O., Condit, P. K., Kasper, C. K., Brown, J. V. and Morrison, F. R. Statewide study of chloramphenicol therapy and fatal aplastic anemia. Journal of the American Medical Association 1969; 208: 2045-2050.
28. Lynch, N. R., Castes, M., Astoin, M. and Salomon, J. C. Mechanism of inhibition of tumor growth by aspirin and indomethacin. British Journal of Cancer 1978; 38: 503-512.
29. Reddy, B. S., Maruyama, H. and Kelloff, G. Dose related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Research 1987; 47: 5340-5346.
30. Giardiello, F. M., Hamilton, S. R., Krush, A. J., et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New England Journal of Medicine 1993; 328: 1313-1316.
31. Giovannucci, E., Egan, K. E., Hunter, D. J., et al. Aspirin and the risk of colorectal cancer in women. New England Journal of Medicine 1995; 333: 609-614.
32. Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D. and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. Journal of the National Cancer Institute 1991; 83: 355-358.
33. Thun, M. J., Namboodiri, M. M. and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. New England Journal of Medicine 1991; 325: 1593-1596.
34. Paganini-Hill, A., Chao, A., Ross, R. K. and Henderson, B. E. Aspirin use and chronic diseases: a cohort study of the elderly. British Medical Journal 1989; 229: 1247-1250.
35. McGee, R., Williams, S. and Elwood, M. Depression and the development of cancer: a meta-analysis. Social Science and Medicine 1994; 38: 187-192.
36. Brandes, L. J., Arron, R. J., Bogdanovic, R. P., et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Research 1992; 52: 3796-3800.
37. Baird, D. T. and Glasier, A. F. Hormonal contraception. New England Journal of Medicine 1993; 328: 1543-1549.
38. Prentice, R. L. and Thomas, D. B. On the epidemiology of oral contraceptives and disease. Advances in Cancer Research 1987; 49: 285-401.
39. Romieu, I., Berlin, J. A. and Colditz, G. Oral contraceptives and breast cancer: review and meta-analysis. Cancer 1990; 66: 2253-2263.
40. Watanabe, S., Tsunematsu, W., Fujimoto, J. and Komiyama, A. Leukemia in patients treated with growth hormone. Lancet 1988; i: 1159-1160.
41. Stahnke, N. Leukemia in growth-hormone-treated patients: an update, 1992. Hormone Research 1992; 38(suppl. 1): 56-62.
42. Watanabe, S., Mizuno, S., Oshima, L. H., Tsunematsu, Y., Fujimoto, J. and Komiyama, A. Leukemia and other malignancies among GH users. Journal of Pediatric Endocrinology 1993; 6: 99-108.
43. Curtis, R. E., Boyce, J. D., Stovall, M., et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. New England Journal of Medicine 1992; 326: 1745-1751.